2m 2m 2m 2m 2m 2m 2m
Viking Therapeut (VKTX)
NASDAQ
$33.94+$0.05 (+0.16%)
Price as of Aug 21, 2026 7:59 PM EDT- $4.0BMarket Cap
- 30.35%1-Year Change
- BiotechnologyIndustry
Viking Therapeut (VKTX)
$33.94+$0.05 (+0.16%)
VKTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $33.89 | ||
Change | -$0.47 (-1.37%) | ||
Open | $34.79 | ||
High | $34.98 | ||
Low | $33.47 | ||
Previous Close | $34.36 | ||
Volume | 1,502,761 | ||
30-Day Average Volume | 1,933,001 | ||
1-Week Change | 2.11% | ||
1-Month Change | -10.70% | ||
1-Year Change | 30.35% | ||
3-Year Change | 138.33% | ||
5-Year Change | 484.31% | ||
Fundamentals | |||
Shares Outstanding | 116.7M | ||
Total Assets | $521.9M | ||
Market Cap | $4.0B | ||
Enterprise Value | $3.8B | ||
Period: QTR TTM FY | |||
Revenue | $30,000.00 | ||
Net Income | -$128.0M | ||
Free Cash Flow | -$125.2M | ||
EBIT | -$128.0M | ||
EBITDA | -$128.0M | ||
Net Working Capital | $407.9M | ||
EPS | -$1.10 | ||
Enterprise Value/EBITDA | -30 | ||
Enterprise Value/Revenue | 127,587 | ||
P/B | 10 | ||
P/E | -31 | ||
PEG | -2 | ||
Price/Free Cash Flow | -32 | ||
Price/Operating Cash Flow | -32 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue